Endocrinology Department

The Endocrinology Department of China-Japan Hospital was established in 1984. It is a key discipline of China-Japan Hospital and was rated as a national key clinical specialty in 2011. The department is a comprehensive medical research and practice center integrating clinical practice, scientific research, and teaching. It is one of the hospital's leading disciplines in the country. The staff composition of the department: the director of the department is chief physician Zhang Bo, and the deputy directors of the department are chief physician Chen Xiaoping and deputy chief physician Song Lulu. The department currently has 9 chief physicians, 3 deputy chief physicians, 10 attending physicians, 3 resident physicians, 2 technicians, and 15 nurses. Among them, 22 have doctorates and 4 have master’s degrees. The proportion of doctors with intermediate and senior professional titles accounts for 88%; those with master's or doctorate degrees or above account for 89.7%; among them, there are 2 doctoral supervisors and 5 master's supervisors. The department is now a doctoral training site and postdoctoral mobile station for endocrinology majors at Union Medical College, Peking University School of Medicine, and the University of Traditional Chinese Medicine. It is also listed as a hospital clinical pharmacology base unit selected by the State Food and Drug Administration.At present, the department has a team of highly educated talents with master's degrees, doctoral degrees, and postdoctoral degrees. All doctors over 40 years old have overseas study and further training backgrounds. They have traveled to the United States, Australia, the Netherlands, Denmark, Singapore, and Japan as visiting scholars, postdoctoral fellows, and doctoral students for training. Many doctors in the department serve as members of the Endocrinology Branch of the Chinese Medical Association, the Diabetes Branch, the Endocrinology and Metabolism Branch of the Chinese Medical Doctor Association, the Endocrinology and Metabolism Branch of the Chinese Geriatrics Society, the Geriatric Osteoporosis Branch of the Chinese Geriatric Healthcare Medical Research Association, the Endocrinology Branch of the Beijing Medical Association, the Osteoporosis and Bone Mineral Salt Society of the Beijing Medical Association, and the Thyroid Disease Expert Committee of the Beijing Medical Association. Over the years, the department has served patients wholeheartedly with superb medical technology, advanced medical testing equipment and good medical ethics, and has been widely praised by patients from all over the country. Professor Yang Wenying, former subject leader and former director of the department, served as Chairman of the Diabetes Branch of the Chinese Medical Association and Vice Chairman of the Asian Diabetes Society. He once served as the editor-in-chief of "Chinese Journal of Diabetes" and the executive editor-in-chief of "JournalofDiabetesInvestigation".He is currently a member of the National Science and Technology Achievement Award Evaluation Committee and a specially appointed expert of the Central Health Commission. It has won many awards including the Second Prize of the Ministry of Health’s Science and Technology Progress Award, the First Prize of the Beijing Science and Technology Progress Award, the Second Prize of the Chinese Medical Association’s Science and Technology Progress Award, and the International Insulin Secretion Research Award. He has published more than 200 medical papers in influential core journals at home and abroad. The internationally renowned journals in which he has published articles as the first author or corresponding author include NEnglJMed, Circulation, Euro-HeartJ, DiabetesCare, etc. He has rich clinical experience in the field of endocrinology and enjoys a high academic status. Professor Li Guangwei, former subject leader and former director of the department, served as deputy director of the 7th and 80th session of the Endocrinology Society Branch of the Chinese Medical Association. He is currently the chairman of the Elderly Health Care Research Association, a member of the Expert Committee on Disease Prevention and Control of the Ministry of Health, and the deputy editor-in-chief of the "Chinese Journal of Endocrinology and Metabolism". It has won the second prize of the Science and Technology Progress Award of the Ministry of Health and the second prize of the Science and Technology Progress Award of the Chinese Medical Association. The main research areas are diabetes, cardiovascular and cerebrovascular disease control and prevention, and insulin-resistant hypertension.The Diabetes Prevention Study in Daqing, China, in which he participated as one of the main members, is known as a milestone in diabetes prevention research in the world. The follow-up study of the Daqing Diabetes Prevention Study completed by the person in charge first reported that lifestyle intervention can reduce the risk of cardiovascular events and death in people with impaired glucose tolerance (IGT). Published hundreds of papers in Chinese and English. The internationally renowned journals in which he has published articles as the first author or corresponding author include Lancet, Lancet Diabetes & Endocrinology, Diabetes Care, Diabetologia, etc. He has rich clinical experience and enjoys a high academic status in the field of endocrinology. The current subject leader, Zhang Bo, Ph.D., chief physician, serves as the chairman of the Diabetes Expert Committee of the National Center for Telemedicine and Internet Medicine. Convenor of the Diabetes Internet Alliance of the National Telemedicine Center, he formulated the first domestic diabetes remote management guideline. In 2019, a second-level branch was created: Endocrinology and Diabetes Branch of Bethune Spiritual Research Institute, and he served as the first president. At present, the society has more than 2,000 members and has established 18 professional committees.The committee members cover 31 provinces, municipalities and autonomous regions, and have gathered a team of specialist doctors who carry forward Bethune's spirit, have excellent business, are closely integrated with the three-level diagnosis and treatment mechanism, and focus on endocrinology and diabetes Internet medical care, promoting the development of domestic Internet medical care. Chief physician Zhang Bo is also a member of the Standing Committee of the Endocrinology Branch of the Chinese Medical Association and the leader of the Adrenal Gland Group. For the first time, he proposed the subject concept of interventional endocrinology, cooperated with brother disciplines, and took the lead in establishing the first interventional endocrinology academic organization in China: the Interventional Endocrinology Professional Committee (study group) of the Endocrinology Branch of the Bethune Spiritual Research Institute. Actively promote the use of minimally invasive non-surgical techniques (interventional microwave ablation, laser ablation, interventional radiotherapy, etc.) to treat endocrine tumors (thyroid, parathyroid, adrenal tumors, etc.) to better provide patients with personalized high-end services. Chief physician Zhang Bo undertook the 13th Five-Year National Key Research and Development Plan project "Research on the current status of control of multiple risk factors, risk prediction models, appropriate intervention technologies and management strategies for high-risk groups for diabetes." Combined with mechanism research and the use of advanced technology, the domestic diabetes prevention field will continue to maintain its leading position in the world. Outpatient clinic and ward settings:The department currently has 11 specialized disease clinics, including: thyroid puncture follow-up clinic, thyroid surgery follow-up clinic, dynamic blood glucose monitoring and insulin pump clinic, obesity and three high clinics, osteoporosis and metabolic bone disease clinic, elderly diabetes management clinic, early-onset diabetes clinic, diabetic neuropathy clinic, pregnancy and endocrine disease clinic, parathyroid disease clinic and pituitary adrenal disease clinic. There are a total of 51 inpatient beds. There are two functional examination rooms, one endocrinology laboratory and one pharmacology base research room. "Introduction to diagnostic and treatment equipment: The Diabetes Prevention and Treatment Research Laboratory has internationally advanced high-tech precision equipment such as chemiluminescence immunoassay analyzers, high-pressure liquid phase HbA1c analyzers, and PCR amplification instruments. It can detect multiple endocrine and metabolic disease indicators such as insulin, thyroid hormones, adrenocortical and medullary hormones, glycosylated hemoglobin, and urinary microalbumin. It has been selected as a centralized laboratory for multi-center drug research across the country many times.The department has a laser Doppler + transcutaneous oxygen partial pressure monitor, a whole-body peripheral vascular examination system, a digital vibration sensory threshold examination system, a color vascular ultrasound diagnostic instrument, a bioimpedance antibody lipid meter, and a fundus camera, which can comprehensively and accurately evaluate various complications of diabetes and perform ultrasound-guided thyroid puncture. Diagnosis and treatment features of the department: The endocrinology department is characterized by the diagnosis of diabetes and thyroid diseases, and can diagnose and treat a variety of endocrine problems and severe diseases: 1. It is a national leader in the fields of diabetes diagnosis, treatment, management, prevention and drug observation. It can complete advanced medical technologies such as mature glucose clamp technology, intensive insulin pump treatment, and continuous dynamic blood glucose monitoring. In addition, the department has established a unique and practical comprehensive management system for diabetes treatment and scientific research in its long-term clinical practice activities, which can provide long-term and effective monitoring and management of various indicators of patients to minimize and delay the occurrence and development of diabetic complications. A number of diabetes-related specialty clinics have been opened, including: early onset diabetes clinic, elderly diabetes management clinic, pregnancy endocrinology and metabolism clinic, diabetes education clinic (education, diet), and diabetic peripheral vascular and neuropathy screening clinic.Provide detailed management for diabetic patients with different conditions. 2. A specialized thyroid puncture follow-up clinic has been opened, and hundreds of thyroid fine-needle aspiration cases are performed every year, which can accurately diagnose thyroid diseases. In February 2012, fine-needle aspiration samples began to be tested for BRAF gene mutations, which has a great advantage in identifying benign or malignant thyroid tumors. 3. The first in China to carry out intensive insulin pump treatment, which can provide some diabetic patients with severely elevated blood sugar (newly diagnosed, disease duration less than 5 years) with the opportunity to control blood sugar well by taking little or no medication for months to years. At present, dynamic blood glucose and insulin pump intensive treatment clinics are launched. 4. A specialized clinic for obesity and high-risk diseases has been opened to systematically diagnose and treat patients with obesity, control their weight, and improve their metabolic disorders such as hyperuric acid, hyperglycemia, and dyslipidemia. Especially for obesity with menstrual disorders, infertility, female hirsutism, etc., comprehensive treatment through weight loss, improvement of insulin sensitivity and other treatment measures has achieved good results.5. A specialized clinic for osteoporosis and bone metabolism has been opened to identify the cause of each osteoporosis patient, check for parathyroid disease, osteomalacia, renal tubular disease, etc., and comprehensively maintain the patient's bone health through diet, exercise and medication. 6. Ranking among the best in the country in the diagnosis and treatment of endocrine and metabolic diseases such as hypothalamus, pituitary gland, adrenal gland, parathyroid gland, gonads, etc. Relying on the advantages of the laboratory, endocrine tests related to pituitary and adrenal diseases can be quickly and accurately performed. Cooperate with neurosurgery/urology department to provide pre- and post-operative management and follow-up for patients with endocrine tumors. The department has also opened specialized outpatient clinics: pituitary gland and adrenal gland specialized outpatient clinics. Specialized clinics for parathyroid diseases, follow-up clinics after thyroid surgery, etc. Existing specialized disease clinics: There are 11 specialized disease clinics, namely: thyroid puncture follow-up clinic, thyroid surgery follow-up clinic, dynamic blood glucose monitoring and insulin pump clinic, obesity and three high clinics, osteoporosis and metabolic bone disease clinic, elderly diabetes management clinic, early onset diabetes clinic, diabetic neuropathy clinic, pregnancy and endocrine disease clinic, parathyroid disease clinic and pituitary adrenal disease clinic. Research achievements of the department:Since the establishment of the hospital, the Department of Endocrinology has achieved fruitful results in scientific research. He has taken the lead in more than 30 research projects, including national “Ninth Five-Year Plan” research projects, National Natural Science Foundation projects, Ministry of Health ministerial projects, Beijing First Fund projects, Chinese Medical Association clinical medical research special fund projects, and hospital-level projects, and has participated in a number of collaborative projects. , such as the national "Eleventh Five-Year Plan", major projects of the Beijing Municipal Science and Technology Commission, projects of the US Centers for Disease Control and Prevention, projects of the World Health Organization, European Diabetes Society Fund projects, national 863 project tissue engineering special projects, Beijing First Fund projects, etc. The department also has long-term and close cooperation with the US Centers for Disease Control and Prevention, the World Health Organization, and the European Society of Diabetes, with research funding of nearly 50 million. Professor Pan Xiaoren, the founder and first director of the department, took the lead in completing the "Daqing Diabetes Prevention Research" from 1986 to 1992.This study is the earliest randomized controlled diabetes prevention clinical trial study in the world for people at high risk of diabetes (impaired glucose tolerance, IGT). It is the first to prove that lifestyle intervention can prevent diabetes. It is a major contribution made by Chinese diabetologists to the world's diabetes prevention research. Together with subsequent similar diabetes prevention studies in the United States and Finland, it is known as a landmark study in the world's primary prevention of type 2 diabetes. Professor Pan Xiaoren also took the lead in completing my country's second large-scale diabetes epidemiological study, the "National Diabetes Prevalence Survey" (1994), which summarized the prevalence and changes of diabetes in my country. Professor Yang Wenying, director of the former department, took the lead in completing the 2007-2008 "National Diabetes Epidemiological Survey". The results of the survey "Study on the Prevalence of Diabetes in the Chinese Population" were published in the world's top medical professional magazine "New England Journal of Medicine". It has laid a solid research foundation for in-depth and effective diabetes prevention and treatment in the whole society. Professor Li Guangwei, director of the former department, led the follow-up study of the Daqing Diabetes Prevention Study and found that the effect of lifestyle intervention in preventing diabetes persists long after the intervention is stopped. The results were published in the famous Lancet magazine in 2008.It was first reported that lifestyle intervention can reduce the risk of cardiovascular events and death in people with IGT. The research results were published in the Lancet sub-journal in 2014 and 2019. Chief Physician Zhang Bo, the department director who is currently in charge of the work, is responsible for the 13th Five-Year National Key Research and Development Plan project "Research on the current status of control of multiple risk factors, risk prediction models, appropriate intervention technologies and management strategies for people at high risk of diabetes". This study combines mechanism exploration to promote the real-world transformation of Daqing's diabetes research results, discover new diabetes prevention targets, and enable the domestic diabetes prevention field to continue to maintain its leading position in the world. Professor Yang Wenying also independently designed and led the study on oral drug initial treatment for newly diagnosed patients with type 2 diabetes in China (MARCH study). The results proved for the first time that the α-glucosidase inhibitor acarbose, as the initial treatment for Chinese patients with type 2 diabetes, was non-inferior to metformin, the only recommended drug in Western guidelines. This result modified the hyperglycemia treatment path in the guideline and was promoted.Originally designed and led the study on the efficacy and safety of dipeptidase peptidase-4 inhibitors combined with α-glucosidase inhibitors, sulfonylureas or metformin (SUCCESS study), which provided new evidence-based evidence for the combined initial treatment of oral medications for type 2 diabetes in the Chinese population. Department experts have published numerous medical papers in influential journals at home and abroad. The department has published more than 300 papers in core journals at home and abroad in the past five years. Internationally renowned journals in which articles have been published as the first author or corresponding author include NEnglJMed, Lancet, LancetDiabetes&Endocrinology, Circulation, Euro-HeartJ, DiabetesCare, etc. Teaching situation of the department: 1. The Sino-Japanese Hospital Endocrinology Forum has been held for five consecutive years and has received good response. 2. The undergraduate department accepts 25-30 training doctors every year. The doctors in the department teach each other what they have learned selflessly, and have won unanimous praise from the training doctors. 3. Complete a number of national continuing education projects sponsored by the hospital, national continuing education projects sponsored by the society, district-level projects and municipal-level projects on schedule every year.4. Train several postgraduate students from Peking University School of Medicine and Beijing University of Chinese Medicine every year. 5. The nursing team teaches more than ten diabetes specialist nurses from all over the country every year. The department has won honors: Our department has won the second prize of the National Science and Technology Progress Award (2007), the second prize of the Ministry of Health Science and Technology Progress Award (1995), the second prize of the Beijing Science and Technology Progress Award (2001), and the third prize of the Chinese Medical Science and Technology Progress Award (200 1) and the International Insulin Secretion Research Award twice (2006, 2007), the second prize of the Chinese Medical Science and Technology Award (2011), the first prize of the Beijing Science and Technology Progress Award (2012), and has also won the China-Japan Friendship Hospital Science and Technology Progress Award many times. In 2011, it was among the first batch to be rated as a national key clinical specialty. Location within the hospital: The endocrinology clinic is located on the 4th floor of the outpatient building, and the inpatient ward is located on the 5th floor of Building J. Department phone number: Outpatient clinic: 010-84205254, Ward: 010-84205712, Nurse station: 010-84205718 In 2018, the former Diabetes Department of Traditional Chinese Medicine was merged into the Department of Endocrinology, which is the second ward of the Department of Endocrinology. The main features are the diagnosis and treatment of diabetes, its acute and chronic complications, and metabolic syndrome using the combination of traditional Chinese and Western medicine. Treatment emphasizes the combination of disease differentiation and syndrome differentiation, and attaches great importance to the integration of traditional Chinese and Western medicine.The department currently undertakes the "Yinhuihe Famous Old Chinese Medicine Practitioner Studio" project of the "3+3" project of the Beijing Municipal Administration of Traditional Chinese Medicine to inherit the torch of traditional Chinese medicine. It has successfully completed the academic inheritance task of traditional Chinese medicine and won the "Beijing Traditional Chinese Medicine Heritage Contribution Award". The department pays attention to the expertise of different doctors, and each doctor has his or her own academic achievements. There is currently 1 chief physician, 3 deputy chief physicians, and 5 attending physicians. Among them, there is 1 national outstanding clinical Chinese medicine talent and 4 doctors. Our department is a high-quality nursing model ward with 26 existing beds, including 4 single rooms, 6 double rooms, and 2 five-person rooms, which can meet the different needs of patients. Features of diagnosis and treatment: 1. Prevent the disease before it occurs, using individualized lifestyle guidance and TCM syndrome differentiation and treatment to improve the abnormal physique of patients with obesity, hypertension, hyperlipidemia, and metabolic syndrome, and prevent the occurrence of diabetes. 2. For patients who are already ill and have no complications from diabetes, they should rationally use drugs for lowering blood sugar, lowering blood pressure, lowering lipids, activating blood circulation and removing blood stasis, etc., to control various indicators to meet the standards; cooperate with traditional Chinese medicine intervention and treatment to prevent and delay the occurrence of complications. 3. Patients with diabetic complications should cooperate with a series of traditional Chinese medicine oral and external treatments (medicated baths, enemas, etc.) to delay the development of complications;Reduce systemic damage and improve patients’ quality of life. 4. There are specialized outpatient clinics for diabetic nephropathy, diabetic peripheral neuropathy, diabetic gastroparesis, etc., which use integrated traditional Chinese and Western medicine to treat symptoms such as edema, numbness, pain, skin itching, abnormal sweating, palpitations, early satiety, alternating diarrhea and constipation. 5. At the same time as drug treatment, patients are given health guidance in terms of fitness and physical education, medicinal diet, psychological adjustment and lifestyle adjustment, so that patients can learn to adopt a healthy lifestyle and benefit from it throughout their lives. It has specialized clinics for TCM diabetic nephropathy, diabetic peripheral neuropathy, diabetic gastroparesis, obesity and other diseases. Location within the hospital: The Traditional Chinese Medicine Clinic of the Department of Endocrinology is located on the 1st floor of Building M, and the inpatient ward is located on the 4th floor of Building J. Department phone: outpatient clinic: 010-84205254, ward: 010-84205712, nurse station: 010-84205718